Back to dataset

UK Inflammatory Bowel Disease (IBD) audit: Round 4 (2012 - 2014) Adult biological therapies data - IBD audit 2014

You're previewing the first 4 rows of this file.

Download this file
Health board / Trust name Sitename Number of patients with Crohn's disease entered at your site Patients with Crohn's disease given 160/80 mg of ADA at induction Response to treatment Remission achieved Patients with at least one adverse event Patients with Crohn's disease on concomittant therapy, 5-ASA at induction Patients with Crohn's disease, treatment effective and discontinued at follow-up
Airedale NHS Foundation Trust Airedale General Hospital 21 3/13 (23%) 5/6 (83%) 4/6 (67%) 2/18 (11%) 1/22 (5%) 0/6 (0%)
Barking Havering & Redbridge University Hospitals NHS Trust King George Hospital and Queens Hospital combined 35 7/12 (58%) N<6 N<6 1/31 (3%) 6/35 (17%) N<6
Barnet and Chase Farm Hospitals NHS Trust Barnet General Hospital 48 29/30 (97%) N=0 N=0 N=0 10/48 (21%) N=0
Barts Health NHS Trust Newham University Hospital 16 N<6 N=0 N=0 1/16 (6%) 3/16 (19%) N<6